Pfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.
Use of the pill, Paxlovid, authorised to treat newly-infected, at-risk people to prevent severe illness, has soared recently as infections rise, reports Reuters.
Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.